Effect of cilostazol on optimized standard antiplatelet therapy in a patient with a cytochrome P450 2C19 *2/*2 genotype

By Fu Qiang  

Cardiovascular Intervention and Therapeutics, Vol. 26, Iss. 1, 2011-01 ,pp. : 79-82

Springer Publishing Company

Access to resources Recommend Favorite

Cytochrome P450 1B1 and 2C9 Genotypes and Risk of Ischemic Vascular Disease, Cancer, and Chronic Obstructive Pulmonary Disease

By  

Current Vascular Pharmacology, Vol. 10, Iss. 4, 2012-01 ,pp. : 512-520

Bentham Science Publishers

Access to resources Recommend Favorite

Cytochrome P450 2D6 as a Model Antigen

By  

Digestive Diseases, Vol. 28, Iss. 1, 2010-05 ,pp. : 80-85

Karger

Access to resources Recommend Favorite

Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study

By Carlquist John   Horne Benjamin   Muhlestein Joseph   Lappé Donald   Whiting Bryant   Kolek Matthew   Clarke Jessica   James Brent   Anderson Jeffrey  

Journal of Thrombosis and Thrombolysis, Vol. 22, Iss. 3, 2006-12 ,pp. : 191-197

Springer Publishing Company

Access to resources Recommend Favorite

No association of estrogen receptor α and cytochrome P450c17α polymorphisms with age at menopause in a Dutch cohort

By Kok Helen S.   Onland-Moret N. Charlotte   van Asselt Kristel M.   van Gils Carla H.   van der Schouw Yvonne T.   Grobbee Diederick E.   Peeters Petra H.M.  

Human Reproduction, Vol. 20, Iss. 2, 2005-02 ,pp. : 536-542

Oxford University Press

Access to resources Recommend Favorite